[Activity Report] The 10th Nikkei FT Communicable Diseases Conference – The AMR Consortium of the Asia Africa Medical Innovation Consortium (AMIC) (October 17, 2023)
date : 12/7/2023
Tags: AMR
The AMR Consortium of the Asia Africa Medical Innovation Consortium, for which AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) serves as the secretariat, discussed antimicrobial resistance (AMR) measures so far during the “Agenda4 – Making Unpredictable Communicable Disease Predictable by Economic Incentives and R&D” in the 10th NIKKEI FT Communicable Diseases Conference, organized by Nikkei INC. and co-sponsored by Financial Times. During the meeting, discussions were held on the progress of AMR measures to date, reflecting on the achievements of the AMR Consortium’s activities. The focus was on the future direction of sustainable research and development in the field of infectious diseases, including economic predictability. In the formulation of statements, input was provided by the AMR Consortium on the evaluation and improvement of the pull-type incentive system, and the establishment of a drug discovery ecosystem that contributes to infection control measures.
[Overview] (titles omitted) ※ Regarding the affiliation, please refer to the list of lecturers for the 10th NIKKEI FT Communicable Diseases Conference.
- Date: Tuesday, October 17, 2023
- Program: Agenda4 – Making Unpredictable Communicable Disease Predictable by Economic Incentives and R&D
NIKKEI FT Infectious Diseases Conference Chairs
Shigeru Omi (Japan Anti-Tuberculosis Association, Chairman, Representative, Board of Director / World Health Organization (WHO), Regional Office for Western Pacific)
Nahoko Shindo (Senior Advisor, WHO Health Emergencies Programme (WHE), World Health Organization)
Agenda4 – Making Unpredictable Communicable Disease Predictable by Economic Incentives and R&D
Moderator
Ryoji Noritake (CEO and Board Member, Health and Global Policy Institute (HGPI))
Discussion (Japanese syllabary order)
Hajime Inoue (Advisor; Health, Nutrition, and Population, The World Bank)
Norio Ohmagari (Director, National Center for Global Health and Medicine Hospital Disease Control and Prevention Center)
Kazumasa Oguro (Professor, Hosei University)
Michikazu Koshiba (Head, Center on Global Health Architecture, MITSUBISHI UFJ RESEARCH AND CONSULTING CO., LTD.)
Takuko Sawada (Director and Vice Chairperson of the Board, Shionogi & Co., Ltd.)
Hirokazu Shimoda (Director, Bio-Industry Division, Ministry of Economy, Trade and Industry (METI))
Manabu Sumi (Cabinet Councilor, Cabinet Agency for Infectious Disease Crises Management (CAICM), Cabinet Office, Government of Japan)
Nozomi Takeshita (Director, Office of Pandemic Preparedness and Response, Division of Infectious Disease Prevention and Control, Department of Infectious Disease Prevention and Control, Public Health Bureau, Ministry of Health, Labour and Welfare)
Yasunori Tawaragi (Environmental Management and Global Health Group Sustainability Promotion Department, DAIICHI SANKYO CO., LTD.)
Kazuhiro Tateda (Professor, Department of Microbiology and Infectious Diseases / Toho University School of Medicine)
Akihisa Harada (President & Representative Director, Pfizer Japan Inc.)
Eiji Hinoshita (Assistant Minister for Global Health and Welfare, Ministry of Health, Labour and Welfare of Japan)
Kyoko Matsumoto (Senior Associate, RDiscovery, KK)
Mitsuru Miyata (CEO, Miyata Institute of Technologies, K.K.)
Malin Grape (Sweden’s Ambassador on Antimicrobial Resistance)
Robert Matiru (Director, Programme Management, Unitaid)
John H. Rex (Chief Medical Officer, F2G Ltd. / Operating Partner, Advent Life Sciences)
日本語
Top Research & Recommendations Posts
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Publication Report] Guidance on Patient and Public Involvement (PPI) in Health Policymaking: Necessary Initiatives and Good Examples from the Public and Government (March 31, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] Healthcare DX Project Research Report of Interviews ”Expectations for the Coming Era of Healthcare DX from People Living with Health Concerns” (June 10, 2024)
- [Policy Recommendations] Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2024 (June 11, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
Featured Posts
-
2024-06-21
[Event Report] HGPI Special Seminar – HGPI Celebrates its 20th Anniversary: Reflecting on HGPI’s Journey from the Past to the Future (January 16, 2024)
-
2024-06-25
[Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
-
2024-06-26
[Event Report] Global Expert Meeting “Innovation in Cancer Care in Developing Countries ~City Cancer Challenge Initiatives“ (June 20, 2024)
-
2024-06-26
[Registration Open] (Webinar) The 127th HGPI Seminar: Current Issues and Future Prospects in Establishing a Health System and Protecting Public Health Through Policy (July 18, 2024)
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)